MedPath

effect of dexmedetomidin on post CABG atrial fibrillatio

Phase 2
Conditions
Atrial fibrillation.
Atrial fibrillation and flutter
Registration Number
IRCT2017021914359N4
Lead Sponsor
Vice Chancellor for research of Guilan university of medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
110
Inclusion Criteria

elective CABG surgery; 35 to 65 year old patients; 3 or more coronary artery stenosis; EF>45%; normal sinus rhythm; normal liver and kidney function. Exclusion criteria: pre-operative diagnosed bradycardia; HR<50; pregnancy; thyroid dysfunction; uncontrolled diabetes; history of corticosteroids use; addiction.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Morphin requirement. Timepoint: within 48 hours after ICU admission. Method of measurement: Visual analogue score.;Onset of atrial fibrillation. Timepoint: Within 24 hours of ICU admission. Method of measurement: ECG 12 lead whenever seen arrhythmia in monitoring and 24 hours monitoring.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath